Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
4.430
-0.030 (-0.67%)
At close: Feb 27, 2026, 4:00 PM EST
4.280
-0.150 (-3.39%)
After-hours: Feb 27, 2026, 7:47 PM EST
Anavex Life Sciences Employees
Anavex Life Sciences had 34 employees as of September 30, 2025. The number of employees decreased by 8 or -19.05% compared to the previous year.
Employees
34
Change (1Y)
-8
Growth (1Y)
-19.05%
Revenue / Employee
n/a
Profits / Employee
-$1,174,912
Market Cap
410.54M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 34 | -8 | -19.05% |
| Sep 30, 2024 | 42 | 2 | 5.00% |
| Sep 30, 2023 | 40 | 2 | 5.26% |
| Sep 30, 2022 | 38 | 13 | 52.00% |
| Sep 30, 2021 | 25 | 5 | 25.00% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bicycle Therapeutics | 305 |
| Puma Biotechnology | 172 |
| Absci | 157 |
| Century Therapeutics | 150 |
| Enanta Pharmaceuticals | 120 |
| Niagen Bioscience | 104 |
| Armata Pharmaceuticals | 60 |
| PureTech Health | 56 |
AVXL News
- 3 days ago - Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference - GlobeNewsWire
- 5 days ago - Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors - GlobeNewsWire
- 19 days ago - Anavex Life Sciences Corp. (AVXL) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 19 days ago - Anavex Life Sciences Reports Fiscal 2026 First Quarter Financial Results and Provides Business Update - GlobeNewsWire
- 25 days ago - Anavex Life Sciences to Announce Fiscal 2026 First Quarter Financial Results on Monday, February 9, 2026 - GlobeNewsWire
- 6 weeks ago - Anavex Life Sciences Corp. (AVXL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 6 weeks ago - Anavex Joins ACCESS-AD, a Major Initiative Funded by the European Commission, Through the Clinical Evaluation of Blarcamesine as Part of a Precision Medicine Approach in Alzheimer's Disease - GlobeNewsWire
- 7 weeks ago - Anavex Life Sciences Appoints Senior Vice President Global Head of Neurology - GlobeNewsWire